Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr mice

Carcinogenesis

Volumn 18, Issue 1, 1997, Pages 233-236

  Sipowicz, Marek A ^d   Weghorst, Christopher M ^a   Shiao, Yih Horng ^a   Buzard, Gregory S ^b   Calvert, Richard J ^c   Anver, Miriam R ^b   Anderson, Lucy M ^a   Rice, Jerry M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC ACTIVE HEPATITIS; EXON; GENE MUTATION; HELICOBACTER; LEUKOCYTE; LIVER CARCINOGENESIS; LIVER HYPERPLASIA; LIVER HYPERTROPHY; LIVER NECROSIS; MOUSE; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS;

ADENOMA; ANIMALS; CARCINOMA; GENE AMPLIFICATION; GENES, BACTERIAL; GENES, P53; GENES, RAS; HELICOBACTER; HELICOBACTER INFECTIONS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED A; POINT MUTATION;

EID: 0031428576     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.1.233     Document Type: Article

References (32)

1. Cover,T.L. and Blaser,M.J. (1995) Helicobacter pylori: a bacterial cause of gastritis, peptic ulcer disease, and gastric cancer. ASM News, 61, 21-26.
2. Parsonnet,J. (1993) Helicobacter pylori and gastric cancer. Gastroenterol. Clinics N Am., 22, 89-104.
3. Fox,D.G., Dewhirst,F.E., Tully,J.G., Paster,B.J., Yan,L., Taylor,N.S., Collins,M.J.,Jr, Gorelick,P.L. and Ward,J.M. (1994) Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J. Clin. Microbiol., 32, 1238-1245.
4. Ward,J.M. et al. (1994) Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl Cancer Inst., 86, 1222-1227.
5. Ward,J.M., Anver,M.R., Haines,D.C. and Benveniste,R.E. (1994) Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am. J. Pathol., 145, 959-968.
6. Wink,D.A. et al. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science, 245, 1001-1003.
7. Stanley,L.A., Devereux,T.R., Foley,J., Lord,P.G., Maronpot,R.R., Orton,T.C. and Anderson,M.W. (1992) Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice. Carcinogenesis, 13, 2427-2433.
8. Manam,S., Storer,R.D., Prahalada,S., Leander,K.R., Kraynak,A.R., Ledwith,B.J., van Zwieten,M.J., Bradley,M.O. and Nichols,W.W. (1992) Activation of Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice. Cancer Res., 52, 1603-1608.
9. Lord,P.G., Hardaker,K.J., Loughlin,J.M., Marsden,A.M. and Orton,T.C. (1992) Point mutation analysis of ras genes in spontaneous and chemically induced C57BL/10J mouse liver tumours. Carcinogenesis, 13, 1383-1387.
10. Wang,Y., Wang,Y., Stoner,G. and You,M. (1993) Ras mutations in 2-acetylaminofluorene- induced lung and liver tumors from C3H/HeJ and (C3HXA/J)F1 mice. Cancer Res., 53, 1620-1624.
11. Chen,B., Liu,L., Castonguay,A., Maronpot,R.R., Anderson,M.W. and You,M. (1993) Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone induced mouse lung tumors. Carcinogenesis, 14, 1603-1608.
12. Enomoto,T., Weghorst,C.M., Ward,J.M., Anderson,L.M., Peratoni,A.O. and Rice,J.M. (1993) Low frequency of H-ras activation in naturally occurring hepatocellular tumors of C3H/HeNCr mice. Carcinogenesis, 14, 1939-1944.
13. Stanley,L.A., Blackburn,D.R., Devereaux,S., Foley,J., Lord,P.G., Maronpot,R.R., Orton,T.C. and Anderson,M.W. (1994) Ras mutations in methylclofenapate-induced B6C3F1 and C57B1/10J mouse liver tumours. Carcinogenesis, 15, 1125-1131.
14. Tabor,E. (1994) Tumor suppressor genes, growth factor genes, and oncogenes in Hepatitis B Viruses-associated hepatocellular carcinoma. J. Med. Virol., 42, 357-365.
15. Goodrow,T.L., Storer,R.D., Leander,K.R., Prahalada,S.R., van Zwieten,M.J. and Bradley,M.O. (1992) Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors. Mol. Carcinogen., 5, 9-15.
16. Kress,S., Konig,J., Schweizer,J., Lohrke,H., Bauer-Hofmann,R. and Schwarz,M. (1992) p53 mutations are absent from carcinogen-induced mouse liver tumors but occur in cell lines established from these tumors. Mol. Carcinogen., 6, 148-158.
17. Calvert,R.J., Tashiro,Y., Buzard,G.S., Diwan,B.A., and Weghorst,C.M. (1995) Lack of p53 mutations in chemically-induced mouse hepatoblastomas: an end-stage, highly malignant hepatocellular tumor. Cancer Lett., 95, 175-180.
18. Vancutsem,P.M., Lazarus,P., and Williams,G.M. (1994) Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen. Cancer Res., 54, 3864-3867
19. Smith,M.L., Yeleswarapu,L., Scalamogna,P., Locker, J. and Lombardi,B. (1993) p53 mutations in hepatocellular carcinomas induced by a choline-devoid diet in male Fischer 344 rats, Carcinogenesis, 14, 503-510.
20. Nakae,D. et al. (1994) Different roles of 8-hydroxyguanine formation and 2-thiobarbituric acid-reacting substance generation in the early phase of liver carcinogenesis induced by a choline-deficient, L-amino acid-defined diet in rats. Jpn. J. Cancer Res., 85, 499-505.
21. Warren,W., Biggs,P.J., El-Baz,M., Ghoneim,M.A., Stratton,M.R. and Venitt,S. (1995) Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between invitational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis, 16, 1181-1189.
22. Sipowicz,M.A., Diwan,B.A., Anver,M.R., North,S.L., Anderson,L.M., Rice,J.M. and Kasprzak,K.S. (1995) Oxidative DNA damage in liver of Helicobacter hepaticus infected mice. Proc. Am. Ass. Cancer Res., 36, 166.
23. Wright,D.K. and Manos,M.M. (1990) Sample preparation from paraffin embedded tissue. In Innis,M.A. (ed.), PCR Protocols: A Guide to Methods and Applications. Academic Press, San Diego, CA, pp. 153-158.
24. Manam,S. and Nichols,W.W. (1991) Multiplex polymerase chain reaction amplification and direct sequencing of homologous sequences: point mutation analysis of the ras genes. Anal. Biochem., 199, 106-111.
25. Hongyo,T., Buzard,G.S., Calvert,R.J. and Weghorst,C.M. (1993) 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res., 21, 3637-3642.
26. Maronpot,R.R., Fox,T., Malarkey,D.E. and Goldsworthy,T.L. (1995) Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology, 101, 125-156.
27. 1 mouse. Proc. Natl Acad. Sci. USA, 83, 5825-5829.
28. Devereux,T.R., Foley,J.F., Maronpot,R.R., Kari,F. and Anderson,M.W. (1993) Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride. Carcinogenesis, 14, 795-801.
29. Anna,C.H., Maronpot,R.R., Pereira,M.A., Foley,J.F., Malarkey,D.E. and Anderson,M.W. (1994) ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis, 15, 2255-2261.
30. Bauer-Hofmann,R., Buchmann,A., Mahr,J., Kress,S. and Schwartz,M. (1992) The tumour promoters dieldrin and phenobarbital increase the frequency of c-Ha-ras wild-type, but not c- Ha-ras mutated focal liver lesions in male C3H/He mice. Carcinogenesis, 13, 477-481.
31. Rumsby,P.C., Evans,J.G., Phillimore,H.E., Carthew,P. and Smith,A.G. (1992) Search for Ha-ras codon 61 mutations in liver caused by haxachlorobenzene and Aroclor 1254 in C57BL/10ScSn mice with iron overload. Carcinogenesis, 13, 1917-1920.
32. Hegi,M.E., Fox,T.R., Belinsky,S.A., Devereux,T.R. and Anderson,M.W. (1993) Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator. Carcinogenesis, 14, 145-149.